News + Media
Latest Updates From ACC
As a global leader in providing high-quality products and services to support life-saving endotoxin and (1→3)-β-D-glucan testing, ACC is at the forefront of innovation in the biopharmaceutical and diagnostics industries. Here, you’ll find the latest updates about our groundbreaking products, industry partnerships, and company milestones.
Explore our latest news below and stay connected with our ongoing mission to protect patient lives and support our customers worldwide.
Press Releases
ACC Achieves Major Regulatory Milestone Advancing Recombinant Endotoxin Testing
A significant milestone has been achieved in the global adoption of recombinant endotoxin testing methods, as Bayer’s Bergkamen site in Germany has secured regulatory approvals.
Fungitell® is awarded FDA Breakthrough Device Designation
Fungitell® testing in the cerebrospinal fluid (CSF) matrix has been granted Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).
ACC Positioned to Help More Biotech Companies
With U.S. Pharmacopeia’s Approval of Chapter <86>, ACC is positioned to help more biotech companies reduce supply chain risk and achieve sustainability goals
Corporate Library
This is your central hub for accessing official ACC products and services literature. Here, you’ll find up-to-date materials designed to support your work and enhance your knowledge of all our products and services.